AnthroTronix and Pelion Healthcare Group Announce Joint Venture to Bring Brain Vital Products to European Market

AnthroTronix and Pelion Healthcare Group Announce Joint Venture to Bring Brain Vital Products to European Market ****** Mobile Tool to Monitor and Evaluate Brain Health Will Now be Available for Consumers and Health Care Professionals Silver Spring, Md. and Łódź, Poland – AnthroTronix and Pelion Healthcare Group have signed a joint venture agreement forming a new company, DANA Brain Vital Europe LTD, with each owning half of the newly established company. The new venture is responsible for developing products based on the DANA platform and distributing them in European markets. Products will be marketed using the “CogniNET” brand within Pelion. DANA, which received FDA clearance in October 2014, is a mobile medical app that can be used on a phone or tablet and works on both the Android and iOS operating systems. DANA administers game-like tests that can provide data within minutes to help assess and measure a person’s brain/cognitive health. The app can help clinicians track cognitive function during treatment for such conditions as depression, dementia/Alzheimer’s Disease, and Post-Traumatic Stress Disorder (PTSD). “We are excited to partner with Pelion to bring DANA not just to health care professionals but also to consumers in Europe,” said Dr. Cori Lathan, @clathan, founder and CEO of AnthroTronix. “Along with tracking and evaluation done by medical professionals, individuals now will be able to track their brain health over time, allowing them to identify patterns in their own cognitive efficiency.” “It is exciting that we can combine 26 years of Pelion’s experience in the healthcare sector and the latest achievements in the area of science represented by AnthroTronix, with the expectations of patients,” said...

AnthroTronix CEO to Present on Digital Technology and the Brain at World Economic Forum 2016 Annual Meeting

AnthroTronix CEO to Present on Digital Technology and the Brain at World Economic Forum 2016 Annual Meeting ****** Dr. Corinna Lathan to Deliver BetaZone Presentation in Davos and Launch the Davos Brain Challenge WHO: AnthroTronix (@AnthroTronix), a leader in digital health technology and engineering research and development committed to optimizing the interaction between people and technology WHAT: Dr. Corinna Lathan (@clathan), AnthroTronix board chair and CEO, will deliver a BetaZone format presentation during the Brain Power session. Dr. Lathan will discuss how digital technology is further allowing us to monitor, diagnose, and understand our brains and how a better understanding of the brain in turn may enable better computer and artificial intelligence (AI) systems. Dr. Lathan has been named a Technology Pioneer and Young Global Leader by the World Economic Forum and is currently chair of their Global Agenda Council on Artificial Intelligence (AI) and Robotics. The overall focus of the session is on the implications for health, education, and privacy of advances in technology that enable us to interpret, hack into, and make changes to the brain. The session will be moderated by Joe Palca, science correspondent for National Public Radio (NPR) and additional speakers for the session include Nina Farahany, professor of law and philosophy at Duke University, and Michael Platt, professor of neuroscience, psychology, and marketing at the Wharton School at the University of Pennsylvania. AnthroTronix is also partnering with Aqtivo Health, and EMOTIV to bring a first-of-its-kind “Davos Brain Challenge” to the World Economic Forum Annual Meeting. Participants are invited to test their brain’s abilities and explore how transformational digital services will shift the way we think...

AnthroTronix Honored As Finalist for 2015 Verl Zanders Emerging Business of the Year

As part of AnthroTronix’s nomination by the Montgomery County Chamber of Commerce (MCCC) for the 2015 Verl Zanders Emerging Business of the Year, our CEO and Board Chair Dr. Cori Lathan was interviewed for the video below. AnthroTronix is honored to have been recognized by the Selection Committee, which states the following as criteria for the award: “This award is presented to a company on the leading edge of innovation by creating milestones in technology and/or business practices that have enhanced earnings and contributed to the County’s reputation as an outstanding place to do...

AnthroTronix CEO to Discuss FDA-Cleared Brain Health Assessment Tool at AARP Dementia Care Technology and Innovation Forum

AnthroTronix CEO to Discuss FDA-Cleared Brain Health Assessment Tool at AARP Dementia Care Technology and Innovation Forum ****** Dr. Cori Lathan to Address the Use of Cognitive mHealth Tools for Individuals with Dementia and their Caregivers Silver Spring, Md. – AnthroTronix (@AnthroTronix) CEO and Board Chair Dr. Cori Lathan(@clathan) will participate in the one-day AARP Dementia Care Technology and Innovation Forum, where she will discuss the AnthroTronix FDA-cleared brain health assessment tool, DANA, and its use as a diagnostic support tool for those at-risk for dementia and for caregivers of those with dementia. WHO: AnthroTronix, an engineering research and development firm committed to optimizing the interaction between people and technology. WHAT: Dr. Cori Lathan will speak on the panel “The Dementia Journey,” which will review the different stages of the dementia journey (diagnosis, therapy, coaching caregivers, social engagement, independent living). The panelists will discuss the exciting approaches and technologies that could be used now and in the future to help with diagnosis and management of dementia to improve the lives both of those who have the disease and their caregivers. Lathan will share her experience developing DANA and how the brain health software platform can be used to indicate changes in cognitive health that could be early indicators of dementia and help dementia caregivers, who are at increased risk for depression due to the physical, mental, and emotional burden of caregiving. Research studies have been conducted using DANA, including one that used the tool to analyze the cognitive effect that ongoing caregiving has on those who serve individuals with dementia and another that studied the stability and reliability of DANA in...

AnthroTronix Featured at Exponential Medicine Conference in San Diego

AnthroTronix Featured at Exponential Medicine Conference in San Diego ****** Dr. Corinna Lathan to Discuss Brain Vitals on November 11; Partner Aqtivo Presenting on Health Risk Assessment for Employers on November 10   WHO: AnthroTronix (@AnthroTronix), an engineering research and development firm committed to optimizing the interaction between people and technology. Aqtivo Health is an mhealth startup developing compelling mobile health and wellness solutions. WHAT: Dr. Corinna Lathan (@clathan), AnthroTronix board chair and CEO, will speak in the Future of the Brain & NeuroMedicine session on the importance of monitoring brain vitals. She will discuss the abilities of AnthroTronix’ FDA-cleared brain health assessment tool, DANA. In a breakout workshop, Aqtivo Health will present a mobile solution being co-developed with AnthroTronix that will provide employers a health risk assessment that includes cognitive health and will engage employees to be more proactive in their own health and wellness. AnthroTronix and Aqtivo Health will also participate in the Healthcare Innovation Lab, a showcase and expo(nential) lab for the most promising companies and innovations that are set to revolutionize the practice of medicine and radically transform healthcare and the biomedical industry. Visitors to their booth will be able to take quick cognitive assessment that should be fun and easy using the AnthroTronix and Aqtivo Health joint app. It will calculate a score, which will go on a leaderboard at the booth next to the username or alias each user has chosen. They will also be able to complete a simplified Health Risk Assessment that will calculate an overall score based on each user’s health and wellness, which will incorporate the cognitive assessment. WHERE:    ...

AnthroTronix CEO Speaks About Healthcare Apps and the Importance of Brain Health at 7th Annual mHealth Summit

AnthroTronix CEO Speaks About Healthcare Apps and the Importance of Brain Health at 7th Annual mHealth Summit ****** Dr. Corinna Lathan Featured on Panel Taking Place November 9 in Washington, D.C. WHO: AnthroTronix (@AnthroTronix), an engineering research and development firm committed to optimizing the interaction between people and technology. WHAT: Dr. Corinna Lathan (@clathan), board chair and CEO of AnthroTronix, will speak on the panel “Optimizing the Patient App Experience: Convergence of Healthcare and Wellness,” which will examine the app development and design process. Lathan will share her personal experience developing DANA, an FDA-cleared brain health assessment tool. DANA, which received FDA clearance in October 2014, is a mobile medical software platform that can be used on a phone or tablet and works on both the Android and iOS operating systems. It’s a game-like tool that can provide data within minutes to help assess and measure a person’s brain/cognitive health. Joining Lathan on the panel will be representatives from Memorial Sloan Kettering Cancer Center, Boston Children’s Hospital and the National Library of Medicine. The panel will be moderated by CEO Michael Fergusson of Ayogo, a company that develops patient engagement software. WHERE: Room: National Harbor 2-3, The Gaylord National Resort and Convention Center, National Harbor, Md. WHEN: Monday, Nov. 9, 2015, 5-6 p.m. The mHealth Summit, part of the HIMSS Connected Health Conference, is the leading conference for developments in the fields of mobile, telehealth and connected health. Sessions will explore the impact these fields have on health care delivery, clinical care and patient/consumer engagement to new technologies, research, investment activities, policy and shifts in the business environment. This...